;PMID: 2056968
;source_file_809.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..35] = [t:0..35]
;1)sentence:[e:40..196] = [t:40..196]
;2)section:[e:200..315] = [t:200..315]
;3)section:[e:319..373] = [t:319..373]
;4)sentence:[e:377..549] = [t:377..549]
;5)sentence:[e:550..648] = [t:550..648]
;6)sentence:[e:649..923] = [t:649..923]
;7)sentence:[e:924..1010] = [t:924..1010]
;8)sentence:[e:1012..1074] = [t:1012..1074]
;9)sentence:[e:1075..1352] = [t:1075..1352]
;10)sentence:[e:1353..1471] = [t:1353..1471]
;11)sentence:[e:1472..1723] = [t:1472..1723]
;12)section:[e:1727..1771] = [t:1727..1771]

;section 0 Span:0..35
;Med Pediatr Oncol  1991;19(4):240-5
(SEC
  (FRAG (NNP:[0..3] Med) (NNP:[4..11] Pediatr) (NNP:[12..17] Oncol)
        (CD:[19..23] 1991) (CD:[23..27] ;19-LRB-) (CD:[27..29] 4-RRB-)
        (CD:[29..33] :240) (::[33..34] -) (CD:[34..35] 5)))

;sentence 1 Span:40..196
;Analysis of N-ras gene mutations in medulloblastomas by polymerase chain 
;reaction and oligonucleotide probes in formalin-fixed, paraffin-embedded 
;tissues.
;[52..57]:gene-rna:"N-ras"
;[76..92]:malignancy:"medulloblastomas"
;[96..106]:gene-protein:"polymerase"
(SENT
  (NP-HLN
    (NP (NN:[40..48] Analysis))
    (PP (IN:[49..51] of)
      (NP
        (NP (NN:[52..57] N-ras) (NN:[58..62] gene) (NNS:[63..72] mutations))
        (PP (IN:[73..75] in)
          (NP (NNS:[76..92] medulloblastomas)))))
    (PP (IN:[93..95] by)
      (NP
        (NP (NN:[96..106] polymerase) (NN:[107..112] chain)
            (NN:[114..122] reaction))
        (CC:[123..126] and)
        (NP (NN:[127..142] oligonucleotide) (NNS:[143..149] probes))))
    (PP (IN:[150..152] in)
      (NP
        (ADJP
          (ADJP (NN:[153..161] formalin) (HYPH:[161..162] -)
                (VBN:[162..167] fixed))
          (,:[167..168] ,)
          (ADJP (NN:[169..177] paraffin) (HYPH:[177..178] -)
                (VBN:[178..186] embedded)))
        (NNS:[188..195] tissues)))
    (.:[195..196] .)))

;section 2 Span:200..315
;Iolascon A, Lania A, Badiali M, Pession A, Saglio G, Giangaspero F, Miraglia
;del  Giudice E, Perrotta S, Cutillo S.
(SEC
  (FRAG (NNP:[200..208] Iolascon) (NNP:[209..210] A) (,:[210..211] ,)
        (NNP:[212..217] Lania) (NNP:[218..219] A) (,:[219..220] ,)
        (NNP:[221..228] Badiali) (NNP:[229..231] M,) (NNP:[232..239] Pession)
        (NNP:[240..241] A) (,:[241..242] ,) (NNP:[243..249] Saglio)
        (NNP:[250..251] G) (,:[251..252] ,) (NNP:[253..264] Giangaspero)
        (NNP:[265..266] F) (,:[266..267] ,) (NNP:[268..276] Miraglia)
        (FW:[277..280] del) (NNP:[282..289] Giudice) (NNP:[290..291] E)
        (,:[291..292] ,) (NNP:[293..301] Perrotta) (NNP:[302..304] S,)
        (NNP:[305..312] Cutillo) (NNP:[313..315] S.)))

;section 3 Span:319..373
;Department of Pediatrics, University of Naples, Italy.
(SEC
  (FRAG (NNP:[319..329] Department) (IN:[330..332] of)
        (NNP:[333..343] Pediatrics) (,:[343..344] ,) (NNP:[345..355] University)
        (IN:[356..358] of) (NNP:[359..365] Naples) (,:[365..366] ,)
        (NNP:[367..372] Italy) (.:[372..373] .)))

;sentence 4 Span:377..549
;Precise data on the incidence of transforming ras oncogenes in pediatric
;tumors  and the correlations with the histopathological properties of the
;tumors are  very limited.
;[423..426]:gene-rna:"ras"
;[440..456]:malignancy:"pediatric tumors"
;[520..530]:malignancy:"the tumors"
(SENT
  (S
    (NP-HLN
      (NP (JJ:[377..384] Precise) (NNS:[385..389] data))
      (PP (IN:[390..392] on)
        (NP
          (NP
            (NP (DT:[393..396] the) (NN:[397..406] incidence))
            (PP (IN:[407..409] of)
              (NP (VBG:[410..422] transforming) (NN:[423..426] ras)
                  (NNS:[427..436] oncogenes)))
            (PP (IN:[437..439] in)
              (NP (JJ:[440..449] pediatric) (NNS:[450..456] tumors))))
          (CC:[458..461] and)
          (NP
            (NP (DT:[462..465] the) (NNS:[466..478] correlations))
            (PP (IN:[479..483] with)
              (NP
                (NP (DT:[484..487] the) (JJ:[488..505] histopathological)
                    (NNS:[506..516] properties))
                (PP (IN:[517..519] of)
                  (NP (DT:[520..523] the) (NNS:[524..530] tumors)))))))))
    (VP (VBP:[531..534] are)
      (ADJP-PRD (RB:[536..540] very) (JJ:[541..548] limited)))
    (.:[548..549] .)))

;sentence 5 Span:550..648
;Additionally the presence of ras activation in medulloblastomas  has not been
;investigated so far.
;[579..582]:gene-rna:"ras"
;[597..613]:malignancy:"medulloblastomas"
(SENT
  (S
    (ADVP (RB:[550..562] Additionally))
    (NP-SBJ-1
      (NP (DT:[563..566] the) (NN:[567..575] presence))
      (PP (IN:[576..578] of)
        (NP (NN:[579..582] ras) (NN:[583..593] activation)))
      (PP-LOC (IN:[594..596] in)
        (NP (NNS:[597..613] medulloblastomas))))
    (VP (VBZ:[615..618] has) (RB:[619..622] not)
      (VP (VBN:[623..627] been)
        (VP (VBN:[628..640] investigated)
          (NP-1 (-NONE-:[640..640] *))
          (ADVP-TMP (RB:[641..643] so) (RB:[644..647] far)))))
    (.:[647..648] .)))

;sentence 6 Span:649..923
;Using a combination of techniques including in  vitro gene amplification by
;polymerase chain reaction (PCR) and detection of  single base mutations by
;sequence-specific oligonucleotides we studied N-ras  activation (mutations at
;codon 12, 13, and 61) in 32 medulloblastomas.
;[725..735]:gene-protein:"polymerase"
;[775..796]:variation-type:"single base mutations"
;[846..851]:gene-rna:"N-ras"
;[865..874]:variation-event:"mutations"
;[878..886]:variation-location:"codon 12"
;[878..883]...[896..898]:variation-location:"codon"..."61"
;[878..883]...[888..890]:variation-location:"codon"..."13"
;[906..922]:malignancy:"medulloblastomas"
(SENT
  (S
    (S-ADV
      (NP-SBJ (-NONE-:[649..649] *))
      (VP (VBG:[649..654] Using)
        (NP
          (NP (DT:[655..656] a) (NN:[657..668] combination))
          (PP (IN:[669..671] of)
            (NP
              (NP (NNS:[672..682] techniques))
              (PP (VBG:[683..692] including)
                (NP
                  (NP
                    (NP
                      (ADJP (FW:[693..695] in) (FW:[697..702] vitro))
                      (NN:[703..707] gene) (NN:[708..721] amplification))
                    (PP (IN:[722..724] by)
                      (NP
                        (NP (NN:[725..735] polymerase) (NN:[736..741] chain)
                            (NN:[742..750] reaction))
                        (NP (-LRB-:[751..752] -LRB-) (NN:[752..755] PCR)
                            (-RRB-:[755..756] -RRB-)))))
                  (CC:[757..760] and)
                  (NP
                    (NP (NN:[761..770] detection))
                    (PP (IN:[771..773] of)
                      (NP
                        (NML (JJ:[775..781] single) (NN:[782..786] base))
                        (NNS:[787..796] mutations)))
                    (PP (IN:[797..799] by)
                      (NP
                        (ADJP (NN:[800..808] sequence) (HYPH:[808..809] -)
                              (JJ:[809..817] specific))
                        (NNS:[818..834] oligonucleotides)))))))))))
    (NP-SBJ (PRP:[835..837] we))
    (VP (VBD:[838..845] studied)
      (NP (NN:[846..851] N-ras) (NN:[853..863] activation))
      (PRN (-LRB-:[864..865] -LRB-)
        (NP
          (NP (NNS:[865..874] mutations))
          (PP-LOC (IN:[875..877] at)
            (NP
              (NP
                (NML-1 (NN:[878..883] codon))
                (CD:[884..886] 12))
              (,:[886..887] ,)
              (NP
                (NML-1 (-NONE-:[887..887] *P*))
                (CD:[888..890] 13))
              (,:[890..891] ,) (CC:[892..895] and)
              (NP
                (NML-1 (-NONE-:[895..895] *P*))
                (CD:[896..898] 61)))))
        (-RRB-:[898..899] -RRB-))
      (PP-LOC (IN:[900..902] in)
        (NP (CD:[903..905] 32) (NNS:[906..922] medulloblastomas))))
    (.:[922..923] .)))

;sentence 7 Span:924..1010
;DNA was  isolated from 20 microns sections of formalin-fixed
;paraffin-embedded tissue.
(SENT
  (S
    (NP-SBJ-1 (NN:[924..927] DNA))
    (VP (VBD:[928..931] was)
      (VP (VBN:[933..941] isolated)
        (NP-1 (-NONE-:[941..941] *))
        (PP (IN:[942..946] from)
          (NP
            (NP (CD:[947..949] 20) (NNS:[950..957] microns)
                (NNS:[958..966] sections))
            (PP (IN:[967..969] of)
              (NP
                (ADJP
                  (ADJP (NN:[970..978] formalin) (HYPH:[978..979] -)
                        (VBN:[979..984] fixed))
                  (ADJP (NN:[985..993] paraffin) (HYPH:[993..994] -)
                        (VBN:[994..1002] embedded)))
                (NN:[1003..1009] tissue)))))))
    (.:[1009..1010] .)))

;sentence 8 Span:1012..1074
;Mutations were found in 3 out of 32 examined medulloblastomas.
;[1012..1021]:variation-event:"Mutations"
;[1057..1073]:malignancy:"medulloblastomas"
(SENT
  (S
    (NP-SBJ-1 (NNS:[1012..1021] Mutations))
    (VP (VBD:[1022..1026] were)
      (VP (VBN:[1027..1032] found)
        (NP-1 (-NONE-:[1032..1032] *))
        (PP-LOC (IN:[1033..1035] in)
          (NP
            (NP (CD:[1036..1037] 3))
            (PP (IN:[1038..1041] out)
              (PP (IN:[1042..1044] of)
                (NP (CD:[1045..1047] 32) (VBN:[1048..1056] examined)
                    (NNS:[1057..1073] medulloblastomas))))))))
    (.:[1073..1074] .)))

;sentence 9 Span:1075..1352
;In all cases only  mutations of codon 61 were found: two of three mutations
;were C to A mutations  at position 1 of the codon 61 (leading to a
;substitution of a glutamine residue  for a lysine) and one was A to T
;mutation at position 3 in the same codon  (glutamine-histidine).
;[1094..1103]:variation-event:"mutations"
;[1107..1115]:variation-location:"codon 61"
;[1141..1150]:variation-event:"mutations"
;[1156..1157]:variation-state-original:"C"
;[1161..1162]:variation-state-altered:"A"
;[1163..1172]:variation-event:"mutations"
;[1177..1203]:variation-location:"position 1 of the codon 61"
;[1218..1230]:variation-type:"substitution"
;[1236..1245]:variation-state-original:"glutamine"
;[1261..1267]:variation-state-altered:"lysine"
;[1281..1282]:variation-state-original:"A"
;[1286..1287]:variation-state-altered:"T"
;[1288..1296]:variation-event:"mutation"
;[1300..1328]:variation-location:"position 3 in the same codon"
;[1331..1340]:variation-state-original:"glutamine"
;[1341..1350]:variation-state-altered:"histidine"
(SENT
  (S
    (S
      (PP (IN:[1075..1077] In)
        (NP (DT:[1078..1081] all) (NNS:[1082..1087] cases)))
      (ADVP (RB:[1088..1092] only))
      (NP-SBJ-1
        (NP (NNS:[1094..1103] mutations))
        (PP (IN:[1104..1106] of)
          (NP (NN:[1107..1112] codon) (CD:[1113..1115] 61))))
      (VP (VBD:[1116..1120] were)
        (VP (VBN:[1121..1126] found)
          (NP-1 (-NONE-:[1126..1126] *)))))
    (::[1126..1127] :)
    (S
      (S
        (NP-SBJ
          (NP (CD:[1128..1131] two))
          (PP (IN:[1132..1134] of)
            (NP (CD:[1135..1140] three) (NNS:[1141..1150] mutations))))
        (VP (VBD:[1151..1155] were)
          (NP-PRD
            (NP
              (NML
                (NML (NN:[1156..1157] C))
                (PP (TO:[1158..1160] to)
                  (NP (NN:[1161..1162] A))))
              (NNS:[1163..1172] mutations))
            (PP-LOC (IN:[1174..1176] at)
              (NP
                (NP (NN:[1177..1185] position) (CD:[1186..1187] 1))
                (PP (IN:[1188..1190] of)
                  (NP (DT:[1191..1194] the) (NN:[1195..1200] codon)
                      (CD:[1201..1203] 61))))))
          (PRN (-LRB-:[1204..1205] -LRB-)
            (VP (VBG:[1205..1212] leading)
              (PP-CLR (TO:[1213..1215] to)
                (NP
                  (NP (DT:[1216..1217] a) (NN:[1218..1230] substitution))
                  (PP (IN:[1231..1233] of)
                    (NP (DT:[1234..1235] a) (NN:[1236..1245] glutamine)
                        (NN:[1246..1253] residue)))
                  (PP (IN:[1255..1258] for)
                    (NP (DT:[1259..1260] a) (NN:[1261..1267] lysine))))))
            (-RRB-:[1267..1268] -RRB-))))
      (CC:[1269..1272] and)
      (S
        (NP-SBJ (CD:[1273..1276] one))
        (VP (VBD:[1277..1280] was)
          (NP-PRD
            (NP
              (NML
                (NML (NN:[1281..1282] A))
                (PP (TO:[1283..1285] to)
                  (NP (NN:[1286..1287] T))))
              (NN:[1288..1296] mutation))
            (PP (IN:[1297..1299] at)
              (NP (NN:[1300..1308] position) (CD:[1309..1310] 3))))
          (PP (IN:[1311..1313] in)
            (NP (DT:[1314..1317] the) (JJ:[1318..1322] same)
                (NN:[1323..1328] codon)))
          (PRN (-LRB-:[1330..1331] -LRB-)
            (NP (NN:[1331..1340] glutamine) (HYPH:[1340..1341] -)
                (NN:[1341..1350] histidine))
            (-RRB-:[1350..1351] -RRB-)))))
    (.:[1351..1352] .)))

;sentence 10 Span:1353..1471
;Our results indicate 10% incidence N-ras mutation in  medulloblastoma, higher
;than in other CNS tumors studied so far.
;[1388..1393]:gene-rna:"N-ras"
;[1407..1422]:malignancy:"medulloblastoma"
;[1445..1455]:malignancy:"CNS tumors"
(SENT
  (S
    (NP-SBJ (PRP$:[1353..1356] Our) (NNS:[1357..1364] results))
    (VP (VBP:[1365..1373] indicate)
      (NP
        (NP
          (NML
            (NML (CD:[1374..1376] 10) (NN:[1376..1377] %))
            (NN:[1378..1387] incidence))
          (NN:[1388..1393] N-ras) (NN:[1394..1402] mutation))
        (PP (IN:[1403..1405] in)
          (NP (NN:[1407..1422] medulloblastoma))))
      (,:[1422..1423] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1423..1423] *))
        (ADJP-PRD
          (ADJP (JJR:[1424..1430] higher))
          (PP (IN:[1431..1435] than)
            (PP (IN:[1436..1438] in)
              (NP
                (NP (JJ:[1439..1444] other)
                   (NN:[1445..1448] CNS) (NNS:[1449..1455] tumors))
                (VP (VBN:[1456..1463] studied)
                  (NP (-NONE-:[1463..1463] *))
                  (ADVP-TMP (RB:[1464..1466] so) (RB:[1467..1470] far)))))))))
    (.:[1470..1471] .)))

;sentence 11 Span:1472..1723
;The main  advantages of the procedure described are its greatly improved
;sensitivity, the  increased speed with which tumor samples can be analyzed,
;and the possibility of  using paraffin-embedded sections to analyze various
;rare tumors in retrospect.
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1472..1475] The) (JJ:[1476..1480] main)
          (NNS:[1482..1492] advantages))
      (PP (IN:[1493..1495] of)
        (NP
          (NP (DT:[1496..1499] the) (NN:[1500..1509] procedure))
          (VP (VBN:[1510..1519] described)
            (NP (-NONE-:[1519..1519] *))))))
    (VP (VBP:[1520..1523] are)
      (NP-PRD
        (NP (PRP$:[1524..1527] its)
          (ADJP (RB:[1528..1535] greatly) (JJ:[1536..1544] improved))
          (NN:[1545..1556] sensitivity))
        (,:[1556..1557] ,)
        (NP
          (NP (DT:[1558..1561] the) (JJ:[1563..1572] increased)
              (NN:[1573..1578] speed))
          (SBAR
            (WHPP-1 (IN:[1579..1583] with)
              (WHNP (WDT:[1584..1589] which)))
            (S
              (NP-SBJ-2 (NN:[1590..1595] tumor) (NNS:[1596..1603] samples))
              (VP (MD:[1604..1607] can)
                (VP (VB:[1608..1610] be)
                  (VP (VBN:[1611..1619] analyzed)
                    (NP-2 (-NONE-:[1619..1619] *))
                    (PP-1 (-NONE-:[1619..1619] *T*))))))))
        (,:[1619..1620] ,) (CC:[1621..1624] and)
        (NP
          (NP (DT:[1625..1628] the) (NN:[1629..1640] possibility))
          (PP (IN:[1641..1643] of)
            (S-NOM
              (NP-SBJ (-NONE-:[1643..1643] *))
              (VP (VBG:[1645..1650] using)
                (NP
                  (ADJP (NN:[1651..1659] paraffin) (HYPH:[1659..1660] -)
                        (VBN:[1660..1668] embedded))
                  (NNS:[1669..1677] sections))
                (S-ADV
                  (NP-SBJ (-NONE-:[1677..1677] *))
                  (VP (TO:[1678..1680] to)
                    (VP (VB:[1681..1688] analyze)
                      (NP (JJ:[1689..1696] various) (JJ:[1697..1701] rare)
                          (NNS:[1702..1708] tumors))
                      (PP (IN:[1709..1711] in)
                        (NP (NN:[1712..1722] retrospect))))))))))))
    (.:[1722..1723] .)))

;section 12 Span:1727..1771
;PMID: 2056968 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1727..1731] PMID) (::[1731..1732] :) (CD:[1733..1740] 2056968)
        (NN:[1741..1742] -LSB-) (NNP:[1742..1748] PubMed) (::[1749..1750] -)
        (NN:[1751..1758] indexed) (IN:[1759..1762] for)
        (NNP:[1763..1771] MEDLINE-RSB-)))
